ProQR share price logo

ProQR

NASDAQ: PRQR

$1.27

-0.06

(-4.51%)

Live

as on

ProQR Stock Performance

as on October 24, 2026 at 6:23 am IST

  • Day's Low

    Day's High

    $1.24
    $1.33
    downward going graph

    2.36%

    Downside

    4.72%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.30
    $3.00
    downward going graph

    -2.36%

    Downside

    136.22%

    Upside

    downward going graph

ProQR share price movements today

Previous Close
$1.33
Open
$1.33
Volume
1.9M
Market Cap
$193.3M
Day's Low - High
$1.24 - $1.33
52 Week Low - High
$1.30 - $3.00

ProQR Historical Returns

1 Month Return
-21.76 %
3 Month Return
-25.7 %
1 Year Return
-52.84 %
3 Year Return
+ 8.13 %
5 Year Return
-82.1 %

ProQR Stock Fundamentals & Key Indicators

Check ProQR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$193.3M

EPS (TTM)

-0.3958

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.08

Industry PE ratio

-3.14

PEG Ratio

-0.53

EBITDA

-29.5M

Revenue (TTM)

18.6M

Profit Margin

92.33%

Return On Equity TTM

-68.44%

ProQR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ProQR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
ProQR image
ProQR
Buy$193.3M-82.10%-3.0892.33%0.00%
Moderna image
Moderna
Neutral$98.1B-37.95%-30.80-12.57%0.00%
BeOne Medicines image
BeOne Medicines
StrongBuy$44.0BNA27.4787.82%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$132.9B191.61%30.2886.04%0.00%
Regeneron image
Regeneron
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for ProQR Stock including INR - Dollar returns

The ProQR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

ProQR investment value today

Current value as on today

₹48,709

Returns

-₹51,291

(-51.29%)

Returns from ProQR Stock

-₹54,965 (-54.96%)

Dollar Impact

₹3,674 (+3.67%)

Analyst Recommendation on ProQR Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for ProQR. Average target price of $7.78

ProQR Share Price Target

Get share price movements and forecasts by analysts on ProQR.

What analysts predicted

83.68%UPSIDE

Target Price

$7.78

Current Price

$1.27

Analyzed by

2 Analysts

High

$8

Target

$7.78

Low

$8

ProQR target price $7.78, a slight upside of 83.68% compared to current price of $1.27. According to 2 analysts rating.

Indian Investors' Interest in ProQR Stock

Search interest for ProQR Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-22% versus previous 30 day period

ProQR Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
4
6
3
4
4
3
2
4
2
8
Gross Profit
4
6
3
4
4
3
2
4
1
8
Operating Income
-8
-3
-8
-10
-10
-12
-11
-9
-13
-
EBITDA
-6
-2
-8
-5
-9
-11
-10
-6
-12
-
Interest Expense
0
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-7
-2
-8
-9
-10
-12
-11
-8
-13
-8
Income Tax Expense
0
0
-
-
-
0
-
0
-
0
Net Income
-7
-2
-8
-9
-10
-12
-11
-8
-13
-8
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
65.86%
91.93%

ProQR Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-1
4
1
1
1
3
6
18
15
Gross Profit
-2
3
-114
1
1
3
6
18
12
Operating Income
-40
-36
-57
-42
-57
-65
-31
-30
-42
EBITDA
1
-35
-170
-48
-54
-56
-24
-24
-36
Interest Expense
0
0
1
2
3
5
1
1
0
Depreciation
1
0
2
2
2
2
2
2
2
Income Before Tax
-43
-37
-56
-46
-60
-64
-27
-27
-40
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-43
-36
-56
-46
-60
-64
-28
-27
-40
Net Profit Margin
165.49%
80.09%
-5943.61%
100.00%
100.00%
100.00%
100.00%
100.00%
83.01%

ProQR Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-7
-2
-8
-9
-10
-12
-11
-8
-13
-8
Operating Cash Flow
-15
-6
-5
-9
-15
-11
-12
-13
-11
-12
Investing Cash Flow
-17
0
16
-2
0
0
0
0
0
0
Financing Cash Flow
0
0
0
71
0
0
0
0
0
49
Change in Cash
-33
-6
10
60
-16
-12
-12
-14
-11
35

ProQR Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-43
-37
-56
-46
-60
-64
-27
-27
-42
Operating Cash Flow
-34
-30
-43
-47
-26
-68
21
-36
-52
Investing Cash Flow
0
0
0
0
0
0
4
-4
-1
Financing Cash Flow
26
88
50
14
136
-30
-2
70
-1
Change in Cash
-11
57
6
-36
111
-92
24
30
-56

Global Institutional Holdings in ProQR

Check out the Institutions with significant holdings in ProQR.

Funds
Holdings
Michael Rockefeller
2.32%
Delaware Group Equity Funds IV
1.32%
Marcia Venegas
0.82%
Xtrackers
0.27%
Kenneth Tropin
0.06%
See all

ProQR News & Key Events

  • img

    Today's Timeline - 23 September

    Wed, 05:30 PM

    -

    ProQR appoints Chris Hart as Chief Data and AI Officer, and Thomas Wolf as strategic AI advisor to enhance RNA editing platform.

Insights on ProQR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -13.60M → -8.87M (in $), with an average increase of 53.3% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.06M → 8.90M (in $), with an average increase of 76.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 724.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 157.7% return, outperforming this stock by 149.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, PRQR stock has moved down by -21.8%

About ProQR

ProQR Therapeutics N.V. operates as a biopharmaceutical enterprise dedicated to discovering and developing RNA-based therapies designed to address genetic disorders. The company's pipeline includes two primary drug candidates in advanced clinical stages: Sepofarsen is currently in a Phase II/III clinical trial, known as the ILLUMINATE trial, targeting Leber Congenital Amaurosis 10 (LCA10). Ultevursen is also undergoing Phase II/III evaluation for the treatment of USH2A-mediated retinitis pigmentosa and Usher syndrome. Beyond its clinical programs, ProQR is actively developing its proprietary Axiomer RNA base-editing platform technology. Strategic collaborations are central to ProQR's strategy, evidenced by its licensing agreements with institutions such as Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center. Furthermore, a significant license and research partnership exists with Eli Lilly and Company, focused on the discovery, advancement, and commercialization of novel medicines for genetic conditions impacting the liver and nervous system. Established in 2012, ProQR Therapeutics N.V. maintains its corporate headquarters in Leiden, the Netherlands.
OrganisationProQR
HeadquartersZernikedreef 9, Leiden, ZH, 2333 Ck, NL
IndustryBiotechnology
CEODaniel Anton de Boer

Key Management of ProQR

Name

Title

Ms. Sheila Sponselee

Chief People & Operations Officer

Ms. Sarah Cue Kiely

Vice President of Investor Relations & Corporate Communications

Mr. Christopher Hart Ph.D.

Chief Data & AI Officer

Dr. Golnar Karimian

Head of Hepatology

Ms. Sandra van der Kolk

Junior Financial Controller

Mr. Daniel Anton de Boer

Founder, CEO & Executive Director

Dr. Gerard Platenburg Ph.D.

Co-Founder, Chief Scientific Officer & Executive Director

Mr. Dennis Hom

Chief Financial Officer

Dr. Cristina Lopez Lopez M.D., Ph.D.

Chief Medical Officer

FAQs

What is ProQR share price today?

ProQR share price today is $1.27 as on . ProQR share today touched a day high of $1.33 and a low of $1.24.

What is the 52 week high and 52 week low for ProQR share?

ProQR share touched a 52 week high of $3.00 on and a 52 week low of $1.30 on . ProQR stock price today i.e. is trending at $1.27,which is 57.67% down from its 52 week high and -2.31% up from its 52 week low.

What is ProQR's market capitalisation today?

ProQR market capitalisation is $0.00T as on .

How to invest in ProQR Stock (PRQR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ProQR on INDmoney app. Click on Buy button.

What is the minimum amount required to buy ProQR Stock (PRQR) from India?

Indian investors can start investing in ProQR (PRQR) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in ProQR stock (as per the Rupee-Dollar exchange rate as on ). Based on ProQR share’s latest price of $1.27 as on October 24, 2026 at 12:53 am IST, you will get 7.8740 shares of ProQR. Learn more about fractional shares .

What are the returns that ProQR has given to Indian investors in the last 5 years?

ProQR stock has given -82.1% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?